Original contributions: Case reportsLiverUse of Terlipressin in an Elderly Patient With Moderate Aortic Valve Stenosis Accompanied by Episodic Atrial Fibrillation During Liver Transplantation: A Case Report

- Intravenous infusion of terlipressin during liver transplantation is considerable management during liver transplantation.
- Terlipressin can be administered for recipient to increase systemic vascular resistance and decrease heart rate during liver transplantation.
- The hemodynamic effects of terlipressin have benefit for elderly end-stage liver disease patients with moderate aortic valve stenosis accompanied by episodic atrial fibrillation.

Anesthesia for patients with moderate aortic stenosis accompanied by atrial fibrillation during high-risk surgery such as liver transplantation remains a challenge in maintaining control of heart rate and maintenance of cardiac output. The action of terlipressin on vasopressin receptors (mainly V1 receptors) leads to splanchnic vasoconstriction and is the key mechanism responsible for increasing systemic vascular resistance and reducing heart rate. We report successful anesthetic management using low-dose terlipressin infusion in an elderly patient who had moderate aortic stenosis with atrial fibrillation during urgent deceased-donor liver transplantation.